587440 Provided is an antibody binding integrin alpha 5 beta 1, comprising specified sequences of the six CDRs. Further provided are antibody variants with mutated Fc region, with increased ADCC activity compared to the un-mutated antibody. The antibody can be used to inhibit growth of tumour cells expressing integrin alpha 5 beta 1.